Skip to main content
TipRanks
Go Ultimate75% OFF

Healthcare Realty Trust (HR) AI Stock Analysis

624 Followers
HR

Healthcare Realty Trust

(NYSE:HR)

Select Model
Rating:65Neutral
Price Target:$20.50â–²(5.89% Upside)
Action:reiterated
Date:11/13/26

The score reflects a balance of improving outlook and momentum versus weaker underlying GAAP profitability. The biggest positives are the strong, guidance-raising earnings call (higher FFO/NOI growth outlook, solid leasing/occupancy progress, and active buybacks) and constructive technical momentum. Offsetting these, financial performance is held back by net losses, sharply negative reported revenue growth, and higher leverage; valuation is mixed with a strong dividend yield but an unsupportive negative P/E.

Positive Factors
Leasing and occupancy momentumImproving occupancy, strong leasing spreads, and a substantial signed-but-not-occupied pipeline support recurring rental income growth. These gains can lift same-store NOI as leases commence, while high retention and longer lease duration improve visibility into future cash flows.
Negative Factors
Persistent net losses and revenue contractionRecurring net losses and sharply contracted reported revenue indicate that strong property-level operating margins are not yet translating consistently into bottom-line profitability. Weak earnings quality can constrain retained capital, reduce financial flexibility, and make results more dependent on adjustments or asset activity.

Healthcare Realty Trust (HR) vs. SPDR S&P 500 ETF (SPY)

-10%-5%0%5%10%15%20%25%30%HR+13.94%SPY+13.11%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
$6.72B
Dividend Yield
4.96%
Average Volume (3M)
4.88M
Price to Earnings (P/E)
-136.1
Beta (1Y)
0.11
Revenue Growth
-6.28%
EPS Growth
77.63%
Country
US
Employees
539
Sector
Real Estate
Sector Strength
65
Industry
REIT - Healthcare Facilities

Healthcare Realty Trust Business Overview & Revenue Model

Company Description

Healthcare Realty Trust operates as a Real Estate Investment Trust (REIT), specializing in the acquisition, development, financing, and active management of income-generating real estate assets, predominantly serving outpatient healthcare providers t...

How the Company Makes Money

Healthcare Realty Trust makes money primarily through rental revenue generated by leasing its healthcare properties to tenants. Key revenue streams generally include: (1) Base rent under long-term leases with healthcare providers, physician groups, h...

Healthcare Realty Trust Earnings Call Summary

Earnings Call Date:Oct 29, 2026(Q3-2026)|% Change Since:8.13%|Next Earnings Date:Feb 12, 2027
Earnings Call SentimentPositive

The call was strongly positive. Management reported solid operating performance, improving occupancy and leasing spreads, raised full-year guidance, maintained a flexible balance sheet, and continued disciplined share repurchases, acquisitions, and dispositions. The principal challenges were higher interest rates, potential transaction-volume moderation, uneven market conditions, higher redevelopment costs, and lower expected fourth-quarter absorption, but these issues were presented as manageable within an otherwise favorable operating environment.

Positive Updates

Strong Third-Quarter Operating Results
Normalized FFO was $0.42 per share, same-store NOI grew 5.1%, the company signed 1.5 million sq ft of leases including 430,000 sq ft of new leases, redevelopment portfolio lease rate reached 72%—up 500 basis points sequentially—and same-store occupancy improved to 93.1%. Cash leasing spreads were 8.6%, and guidance was raised for the third time this year.

Negative Updates

Higher Interest Rates Weigh on Real Estate Stocks
Management acknowledged that higher interest rates have weighed on real estate stocks, including Healthcare Realty's shares. The company said its stock was trading at a meaningful and significant discount to NAV.

Company Guidance

Healthcare Realty raised full-year normalized FFO per share guidance to $1.65-$1.67, with a midpoint of $1.66, and raised full-year same-store cash NOI growth guidance to 5%-5.25%; sources and uses of capital increased by $85 million to reflect incremental share repurchases and JV acquisitions at share, while disposition guidance increased by the same amount. The company said guidance only reflects acquisitions, redevelopments, or other uses of capital announced to date, is going to keep trying to get cash leasing spreads in the 5% area, if not better, and expects its average disposition yield for the year to be in the mid-5% range; its $50 million-$100 million acquisition range remains applicable, leverage is consistent with the mid-5x target in its 2026 guidance, retention for 2027 expiring square footage is expected to be in the mid to high 80s, the SNO pipeline could bring same-store occupancy closer to 94%, total occupancy is trending towards right around 91%, and $40 million of the $50 million of NOI targeted for recapture is expected over the course of the three-year plan, more backend weighted.

Healthcare Realty Trust Financial Statement Overview

Summary

Operating metrics and cash generation are supportive (TTM EBITDA margin ~63% and positive TTM free cash flow of ~$168.6M), but overall results are constrained by persistent net losses (TTM net margin ~-4.0%), sharply negative reported revenue growth (-97.2%), and rising leverage (debt-to-equity ~1.10) with negative ROE.

Income Statement

34Negative

Balance Sheet

52Neutral

Cash Flow

63Positive
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue1.13B1.18B1.27B1.34B932.64M534.82M
Gross Profit465.28M-396.46M-555.43M-618.09M-317.56M-82.88M
EBITDA714.25M519.96M313.79M762.47M660.40M325.69M
Net Income-44.93M-246.07M-654.49M-278.26M40.90M66.66M
Balance Sheet
Total Assets8.96B9.21B10.65B12.64B13.85B4.26B
Cash, Cash Equivalents and Short-Term Investments17.50M26.17M68.92M25.70M60.96M13.18M
Total Debt4.49B4.15B4.96B5.30B5.70B1.92B
Total Liabilities4.83B4.53B5.35B5.71B6.17B2.07B
Stockholders Equity4.08B4.62B5.23B6.82B7.57B2.19B
Cash Flow
Free Cash Flow168.56M126.94M252.64M268.79M109.20M131.94M
Operating Cash Flow449.69M457.10M501.62M499.82M272.75M232.63M
Investing Cash Flow412.74M710.83M900.92M349.14M1.63B-562.47M
Financing Cash Flow-888.43M-1.21B-1.36B-884.22M-1.86B327.72M

Healthcare Realty Trust Technical Analysis

Technical Analysis SentimentPositive
Last Price19.36

Price Trends

50DMA18.00Positive
100DMA18.88Positive
200DMA18.53Positive

Market Momentum

MACD0.44Negative
RSI65.78Neutral
STOCH63.10Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HR, the sentiment is Positive. The current price of 19.36 is above the 20-day moving average (MA) of 18.66, above the 50-day MA of 18.00, and above the 200-day MA of 18.53, indicating a bullish trend. The MACD of 0.44 indicates Negative momentum. The RSI at 65.78 is Neutral, neither overbought nor oversold. The STOCH value of 63.10 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HR.

Healthcare Realty Trust Risk Analysis

Healthcare Realty Trust disclosed 42 risk factors in its most recent earnings report. Healthcare Realty Trust reported the most risks in the "Finance & Corporate" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

3 New Risks
1.The Company's results of operations have been and will continue to be impacted negatively by the Steward Health and Prospect Medical bankruptcies.Q4, 2024
2.The Company's success depends, in part, on its ability to attract and retain talented employees. The loss of any one of the Company's key personnel or the inability to maintain appropriate staffing could adversely impact the Company's business.Q4, 2024
3.The Company's results of operations have been and will continue to be impacted by the Steward Health bankruptcy.Q3, 2024

Healthcare Realty Trust Peers Comparison

Overall Rating

UnderperformOutperform
Sector (65)

Financial Indicators

HR against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
CTRECTRE77Outperform$9.78B23.578.10%3.97%43.65%17.90%
NHINHI77Outperform$3.07B4.3841.65%5.93%28.04%347.16%
LTCLTC75Outperform$2.37B4.3039.59%5.47%68.94%1200.88%
SBRASBRA72Outperform$5.40B73.642.55%5.82%21.20%-61.51%
Sector *65Neutral$2.17B12.193.79%4.94%3.15%1.96%
HRHR65Neutral$6.55B-136.05-1.04%4.96%-6.28%77.63%

* Real Estate Sector Average

Performance Comparison

0%20%HRLTCNHISBRACTREDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
HR and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
HRHealthcare Realty Trust Incorporated19.362.7016.21%
LTCLtc Properties41.717.8523.17%
NHINational Health Investors62.43-11.97-16.09%
SBRASabra Healthcare Reit20.623.1317.90%
CTRECareTrust REIT37.953.169.09%

Healthcare Realty Trust Corporate Events

Business Operations and StrategyStock BuybackDividendsFinancial Disclosures

Healthcare Realty Trust Posts Q3 Loss, Lifts 2026 Guidance

Positive
Oct 29, 2026

Healthcare Realty Trust reported third-quarter 2026 results on October 29, 2026, posting a GAAP net loss of $0.05 per share but delivering NAREIT FFO of $0.38 per share, Normalized FFO of $0.42 per share and a 5.1% same-store cash NOI increase, suppo...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 13, 2026